drugset / Trial / NCT05078827

Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis

NCT05078827 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Fluorouracil is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites.

Timeline

Start
2022-03-01
Primary completion
2022-11-01
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule 5 % Topical

Indications